Optimizing IT and data management to help companies effectively and efficiently develop new therapies
Today’s research approaches are being impacted by data volume and complexity, new database technology, and the need to distribute information across the organization.
Our Research and Development capabilities include:
Ensuring quality in the IT systems that support drug discovery, research, clinical, and commercial operations
Whenever patient safety is involved, IT systems are subject to substantial regulatory compliance and strict adherence to applicable rules and regulations.
Our IT Quality capabilities include:
Helping ensure patient safety and navigate the evolving regulatory environment
Patient safety is at the heart of Life Sciences companies’ mission, guided by the regulatory infrastructure of multiple entities, such as the FDA, across the globe.
Our Safety and Regulatory capabilities include:
Helping emerging and maturing Life Sciences companies solve technical challenges as their businesses evolve
Smaller companies need to develop new front-office capabilities for product launches, new selling models, and product acquisition.
Mature companies that expand into new markets require planning and execution to integrate new therapies with existing commercial footprints.
Our Commercial capabilities include:
Moving to the cloud with core business processes like order-to-cash, procure-to-pay, and supply chain management
Life Sciences companies have very challenging solution environments as they move ERP systems from on-premises to cloud and begin to implement core back office systems.
Our Enterprise Services capabilities include:
Leading complex projects and programs to ensure the success of critical business functions
Life Sciences companies need strong oversight, governance, and management to ensure success in complex processes and systems—be it R&D or large sales and operations functions.
Our Program & Project Management capabilities include:
"Congratulations on the move to Hawkins Point. Know them well. They have a sterling reputation."
– CIO, Biotech